These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 7707325

  • 1. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD, van Zijl P, Denny WA, Wilson WR.
    J Med Chem; 1995 Mar 31; 38(7):1229-41. PubMed ID: 7707325
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.
    Palmer BD, Wilson WR, Cliffe S, Denny WA.
    J Med Chem; 1992 Aug 21; 35(17):3214-22. PubMed ID: 1507207
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
    Palmer BD, Wilson WR, Pullen SM, Denny WA.
    J Med Chem; 1990 Jan 21; 33(1):112-21. PubMed ID: 2296009
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5.
    Kestell P, Pruijn FB, Siim BG, Palmer BD, Wilson WR.
    Cancer Chemother Pharmacol; 2000 Jan 21; 46(5):365-74. PubMed ID: 11127940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.
    Helsby NA, Wheeler SJ, Pruijn FB, Palmer BD, Yang S, Denny WA, Wilson WR.
    Chem Res Toxicol; 2003 Apr 21; 16(4):469-78. PubMed ID: 12703963
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD, Wilson WR, Atwell GJ, Schultz D, Xu XZ, Denny WA.
    J Med Chem; 1994 Jul 08; 37(14):2175-84. PubMed ID: 8035424
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M, Wilson WR, Anderson RF, Denny WA.
    J Med Chem; 1996 Mar 01; 39(5):1084-94. PubMed ID: 8676343
    [Abstract] [Full Text] [Related]

  • 9. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E, Parkinson GN, Denny WA, Neidle S.
    J Med Chem; 2003 Sep 11; 46(19):4009-20. PubMed ID: 12954054
    [Abstract] [Full Text] [Related]

  • 10. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.
    Anlezark GM, Melton RG, Sherwood RF, Wilson WR, Denny WA, Palmer BD, Knox RJ, Friedlos F, Williams A.
    Biochem Pharmacol; 1995 Aug 25; 50(5):609-18. PubMed ID: 7669063
    [Abstract] [Full Text] [Related]

  • 11. Reduction of nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine by radiation.
    Wilson WR, Ferry DM, Tercel M, Anderson RF, Denny WA.
    Radiat Res; 1998 Mar 25; 149(3):237-45. PubMed ID: 9496886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.
    Hay MP, Denny WA, Wilson WR.
    Anticancer Drug Des; 1996 Jul 25; 11(5):383-402. PubMed ID: 8765531
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and hypoxia-selective cytotoxicity of a 2-nitroimidazole mustard.
    Lee HH, Palmer BD, Wilson WR, Denny WA.
    Bioorg Med Chem Lett; 1998 Jul 07; 8(13):1741-4. PubMed ID: 9873426
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and bioevaluation of a series of fatty acid esters of p-[N,N-bis(2-chloroethyl)amino]phenol.
    Wynn JE, Caldwell ML, Robinson JR, Beamer RL, Bauguess CT.
    J Pharm Sci; 1982 Jul 07; 71(7):772-6. PubMed ID: 7120060
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and bioevaluation of a series of alkyl ethers of p-N,N-bis(2-chloroethyl)aminophenol.
    Wise JW, Wynn JE, Beamer RL, Bauguess CT.
    J Pharm Sci; 1982 May 07; 71(5):561-5. PubMed ID: 7097504
    [Abstract] [Full Text] [Related]

  • 19. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
    Sykes BM, Atwell GJ, Hogg A, Wilson WR, O'Connor CJ, Denny WA.
    J Med Chem; 1999 Feb 11; 42(3):346-55. PubMed ID: 9986704
    [Abstract] [Full Text] [Related]

  • 20. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG, Atwell GJ, Wilson WR.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1593-604. PubMed ID: 7980625
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.